# Xpeng Inc.: overview

XPEV · NYSE · CIK 1810997 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xpev.md) · [Financials](/companies/xpev/financials.md) · [Filings](/companies/xpev/filings.md) · [Insiders](/companies/xpev/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2020 (2020-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [896](/filings/0001193125-21-118515.md) | not reported | not reported | not reported | not reported |
| Gross margin | % | [4.6%](/filings/0001193125-21-118515.md) | not reported | not reported | not reported | not reported |
| Operating margin | % | [(73.5%)](/filings/0001193125-21-118515.md) | not reported | not reported | not reported | not reported |
| Net margin | % | [(46.7%)](/filings/0001193125-21-118515.md) | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [(0.99)](/filings/0001193125-21-118515.md) | [5.34](/filings/0001193125-25-082001.md) | [(5.96)](/filings/0001193125-26-157849.md) | [(3.06)](/filings/0001193125-26-157849.md) | [(0.60)](/filings/0001193125-26-157849.md) |
| Free cash flow | $m | [(145)](/filings/0001193125-21-118515.md) | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xpev/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Alibaba Group Holding Ltd](/funds/1577552.md) | 2026-06-30 | $444.0m | 33,537,232 |  | Unchanged |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $165.7m | 12,515,757 |  | Reduced −217,230 |
| [TMT General Partner Ltd](/funds/1847582.md) | 2026-06-30 | $136.2m | 10,285,837 |  | Unchanged |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $126.9m | 9,586,523 |  | Added +4,137,650 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $111.7m | 8,439,100 | Call | Added +2,029,800 |
| [Ghisallo Capital Management LLC](/funds/1825214.md) | 2026-06-30 | $99.3m | 7,500,000 |  | Unchanged |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $73.9m | 5,580,085 |  | Added +1,175,443 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $53.4m | 4,036,718 |  | Added +2,722,808 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $52.0m | 3,937,514 |  | Added +165,989 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $48.6m | 3,671,997 |  | Added +1,852,544 |

## Recent filings

[All 326 filings](/companies/xpev/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 15:44 ET | [6-K](/filings/0001193125-26-423624.md) | Report of a foreign private issuer, period 2026-10-16 | 0001193125-26-423624 |
| 2026-10-02 | 11:09 ET | [6-K](/filings/0001193125-26-411251.md) | Report of a foreign private issuer, period 2026-10-02 | 0001193125-26-411251 |
| 2026-09-28 | 10:29 ET | [6-K](/filings/0001193125-26-403321.md) | Report of a foreign private issuer, period 2026-09-28 | 0001193125-26-403321 |
| 2026-09-01 | 10:10 ET | [6-K](/filings/0001193125-26-377441.md) | Report of a foreign private issuer, period 2026-09-01 | 0001193125-26-377441 |
| 2026-08-25 | 10:03 ET | [6-K](/filings/0001193125-26-364050.md) | Report of a foreign private issuer, period 2026-08-25 | 0001193125-26-364050 |
| 2026-08-24 | 10:45 ET | [6-K](/filings/0001193125-26-361758.md) | Report of a foreign private issuer, period 2026-08-24 | 0001193125-26-361758 |
| 2026-08-04 | 12:50 ET | [6-K](/filings/0001193125-26-331640.md) | Report of a foreign private issuer, period 2026-08-04 | 0001193125-26-331640 |
| 2026-08-03 | 11:13 ET | [6-K](/filings/0001193125-26-329541.md) | Report of a foreign private issuer, period 2026-08-03 | 0001193125-26-329541 |
| 2026-07-15 | 14:32 ET | [6-K](/filings/0001193125-26-304222.md) | Report of a foreign private issuer, period 2026-07-15 | 0001193125-26-304222 |
| 2026-07-02 | 10:34 ET | [6-K](/filings/0001193125-26-293394.md) | Report of a foreign private issuer, period 2026-07-02 | 0001193125-26-293394 |

## Latest annual report

[Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-157849.md), filed Apr 16, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1810997
- Tickers: XPEV, XPNGF
- Exchange: NYSE
- SIC code: 3711 Motor Vehicles & Passenger Car Bodies
- State of incorporation: E9
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.
